Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Non-Current Assets: 2013-2020

Historic Non-Current Assets for Larimar Therapeutics (LRMR) over the last 7 years, with Sep 2020 value amounting to $6.1 million.

  • Larimar Therapeutics' Non-Current Assets fell 34.97% to $6.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $6.1 million, marking a year-over-year decrease of 34.97%. This contributed to the annual value of $451,000 for FY2019, which is 4.40% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Non-Current Assets of $6.1 million as of Q3 2020, which was down 3.23% from $6.3 million recorded in Q2 2020.
  • Larimar Therapeutics' 5-year Non-Current Assets high stood at $9.9 million for Q2 2019, and its period low was $432,000 during Q4 2018.
  • Its 3-year average for Non-Current Assets is $4.4 million, with a median of $2.7 million in 2019.
  • Its Non-Current Assets has fluctuated over the past 5 years, first slumped by 47.43% in 2017, then surged by 1,884.03% in 2019.
  • Quarterly analysis of 5 years shows Larimar Therapeutics' Non-Current Assets stood at $722,000 in 2016, then fell by 18.98% to $585,000 in 2017, then dropped by 26.15% to $432,000 in 2018, then rose by 4.40% to $451,000 in 2019, then slumped by 34.97% to $6.1 million in 2020.
  • Its last three reported values are $6.1 million in Q3 2020, $6.3 million for Q2 2020, and $9.0 million during Q1 2020.